1) Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid:Prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98:31-40.
2) Mansour J, Sagiv D, Alon E, Talmi Y. Prognostic value of lymph node ratio in metastatic papillary thyroid carcinoma. J Laryngol Otol. 2018;132:8-13.
3) Hutter RV, Frazell EL, Foote FW Jr. Elective radical neck dissection:An assessment of its use in the management of papillary thyroid cancer. CA Cancer J Clin. 1970;20:87-93.
4) Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma:A population-based, nested case-control study. Cancer. 2006;106:524-531.
5) Bhattacharyya N. Surgical treatment of cervical nodal metastases in patients with papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:1101-1104.
11) Muzza M. The clonal origin of multifocal papillary thyroid cancer (MPTC):Intrathyroid spread or independent tumors. Minerva Endocrinol. In press; 2020.
12) Joseph KR, Edirimanne S, Eslick GD. Multifocality as a prognostic factor in thyroid cancer:A meta-analysis. Int J Surg. 2018;50:121-125.
13) Choi WR, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, et al. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence. Oral Oncol. 2019;94:106-110.
14) Harries V, Wang LY, McGill M, Xu B, Tuttle RM, Wong RJ, et al. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma? Surgery. 2020;167:10-17.